D-Phenylalanine-bortezomib is an impurity of Bortezomib (B675700), which is the first proteasome inhibitor drug used to treat cancer in humans. It is related to stereoisomer N-(2-Pyrazinylcarbonyl)-L-phenylalanyl-N-[(1R)-1-borono-3-methylbutyl]-L-phenyla
Molecular Weight:
531.41
* VAT and and shipping costs not included. Errors and price changes excepted